Close
  Indian J Med Microbiol
 

Figure 4: Herniarin restored the altered lipid-metabolizing enzyme and glycolytic enzymes. Where (a) analysis of LCAT, LL, and TL activity in plasma samples, (b) analysis of LCAT, LL, TL, CES, and CEH activity in liver tissue samples, and (c) estimation of HK and AL of all groups of animals where each value shows mean ± standard error of mean (n = 6); where a – Groups II, III, and IV compared with Group I; b – Groups III and IV compared to Group II; ***P < 0.001; **P < 0.01; *P < 0.05;nsp > 0.05; Group I – Control; Group II – Induced control (DMBA, 20 mg), Group III – DMBA (20 mg) + herniarin (20 mg/kg, b. w.); Group IV – DMBA (20 mg) + herniarin (40 mg/kg, b. w.). DMBA: 7,12-dimethylbenz(a)anthracene; LCAT: lecithin–cholesterol acyltransferase; LL: Lipoprotein lipase; TL: Total lipase; CES: Cholesterol ester synthetase; CEH: Cholesterol ester hydrolase; HK: Hexokinase; AL: Aldolase

Figure 4: Herniarin restored the altered lipid-metabolizing enzyme and glycolytic enzymes. Where (a) analysis of LCAT, LL, and TL activity in plasma samples, (b) analysis of LCAT, LL, TL, CES, and CEH activity in liver tissue samples, and (c) estimation of HK and AL of all groups of animals where each value shows mean ± standard error of mean <i>(n</i> = 6); where a – Groups II, III, and IV compared with Group I; b – Groups III and IV compared to Group II; ***<i>P</i> < 0.001; **<i>P</i> < 0.01; *<i>P</i> < 0.05;<sup>ns</sup>p > 0.05; Group I – Control; Group II – Induced control (DMBA, 20 mg), Group III – DMBA (20 mg) + herniarin (20 mg/kg, b. w.); Group IV – DMBA (20 mg) + herniarin (40 mg/kg, b. w.). DMBA: 7,12-dimethylbenz(a)anthracene; LCAT: lecithin–cholesterol acyltransferase; LL: Lipoprotein lipase; TL: Total lipase; CES: Cholesterol ester synthetase; CEH: Cholesterol ester hydrolase; HK: Hexokinase; AL: Aldolase